The soaring demand for antibiotics, on account of the alarming rise in the prevalence of various infections and food-borne diseases, has provided a significant thrust to microbiology culture practices across the world over the last few years. According to the Centers for Disease Control and Prevention (CDC), in the U.S. alone, a total of 23.6 million cases of infectious and parasitic diseases were reported in 2010. Since microbiology culture is an efficient diagnosis method to detect the cause of a number of infectious diseases, its application in the production of antibiotic drugs is witnessing a remarkable rise, worldwide.
Obtain the Upcoming Market Trends of Microbiology Culture at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3232
The consumption of antibiotics is also experiencing a sturdy growth in the BRICS nation. A 2014 report by Lancet Infectious Diseases Commission stated that the consumption of antibiotic drugs increased globally by 36% from 2000 to 2010, wherein BRICS countries accounted for a share of 76% of this growth. All these factors, together, point towards an opportunity-rich future for the worldwide market for microbiology culture over the coming years.
BRICS Nations to Present Opportunities for Growth Due to Increased Antibiotic Consumption
“The rapid rise in the demand for antibiotics has had a lasting effect on the practice of microbiology culture,” states an analyst at TMR. Antibiotics are secondary metabolites produced by microorganisms and utilized in the treatment of a number of bacterial and protozoan infections. Mostly, antibiotics are naturally occurring; however, the quantity available in the natural environment is far less than the required quantity for large-scale production. Hence, microbes are cultured under controlled conditions to increase their biomass and to separate the antibiotics from them.
According to Lancet Infectious Diseases Commission, the consumption of antibiotic drugs witnessed a rise by 36% during the period from 2000 to 2010 with the BRICS nations holding a share of 76% of this increase. The high prevalence of infectious diseases, the rising healthcare expenditure, and the increasing access to antibiotic drugs have driven the consumption of antibiotics in these countries since the last decade and are likely to do so in the years to come. Owing to this, the demand for microbial culture is also expected to increase significantly over the next few years.
High Cost Associated with Culture Media to Limit Demand for Microbiology Culture
On the other hand, the market may face severe challenges from the high costs associated with culture media and the continual functioning of fermentation vessel over several weeks. The difficulty in the identification of alternative nutrient sources for the growth of various microorganisms in order to meet the specific requirements and to reduce the cost of large-scale fermentation are also expected to hamper microbial culture practices to some extent in the near future.
The advent of recombinant technology, however, is anticipated to offer lucrative growth opportunities to players operating in the global market for microbiology culture over the forthcoming years.
Asia Pacific to Exhibit Fastest Growth Rate
On account of the increased funding by several governments in the field of microbiology, North America and Europe has acquired the first two positions in the global microbiology culture market. In 2014, North America topped the list with a share of 35.4%, whereas Europe closely followed with 32.0%. Analysts expect North America to remain the key regional market; however, Asia Pacific is likely to report the growth at the fastest cumulative average rate of 6.80% between 2015 and 2023.
Bacterial culture headed the global market in 2014 and is expected to continue to lead in the near future. Complex media is likely to remain the most preferred culture media over the next few years.
On the whole, the opportunity in the global market for microbial culture is likely to rise at a CAGR of 5.90% between 2015 and 2023, increasing from US$4.5 bn in 2014 to an estimated value of US$7.6 bn by the end of the forecast period.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453